Eliem Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Compra con información privilegiada: Datos insuficientes para determinar si personas con información privilegiada han comprado más acciones de las que han vendido en los últimos 3 meses.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 713.641 | 2,57 % |
Individual Insiders | 836.242 | 3,02 % |
Hedge Funds | 2.180.000 | 7,86 % |
Institutions | 3.823.259 | 13,8 % |
Private Companies | 5.012.855 | 18,1 % |
VC/PE Firms | 15.153.412 | 54,7 % |
Dilución de acciones: Los accionistas se han diluido en el último año, con un crecimiento del total de acciones en circulación de 3.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
13.150.849 | US$36.7m | 0 % | 0,5 % | |||
5.009.400 | US$14.0m | 0 % | no data | |||
2.180.000 | US$6.1m | 12,5 % | 4,2 % | |||
2.002.563 | US$5.6m | 0 % | 100,0 % | |||
1.461.538 | US$4.1m | 0 % | no data | |||
841.087 | US$2.3m | 0 % | 1,98 % | |||
811.680 | US$2.3m | 0 % | 0,02 % | |||
487.460 | US$1.4m | 0 % | no data | |||
310.486 | US$866.3k | 0,21 % | no data | |||
178.100 | US$496.9k | 0 % | no data | |||
170.682 | US$476.2k | 135 % | no data | |||
78.276 | US$218.4k | -0,77 % | 0,04 % | |||
66.626 | US$185.9k | 0 % | no data | |||
55.223 | US$154.1k | 0 % | no data | |||
48.712 | US$135.9k | 336 % | no data | |||
31.145 | US$86.9k | -0,53 % | no data | |||
29.490 | US$82.3k | -0,72 % | no data | |||
21.700 | US$60.5k | 0 % | no data | |||
18.423 | US$51.4k | -68,4 % | no data | |||
13.821 | US$38.6k | 0 % | no data | |||
12.160 | US$33.9k | -5,04 % | no data | |||
10.603 | US$29.6k | 0 % | no data | |||
8333 | US$23.2k | 0 % | no data | |||
3455 | US$9.6k | -11,3 % | no data | |||
1709 | US$4.8k | 0 % | no data |